AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Covid-19 Vaccine Makers in News: J&J, AstraZeneca and Pfizer
April 14, 2021 07:45 PM AEST| By Suhita PoddarSource: insta_photos, Shutterstock Summary J&J delays the distribution of its Covid-19 vaccine to Europe. US may not use the AstraZeneca vaccine, says the chief pandemic adviser to the White House. Pfizer is likely to meet its US supply t...
AstraZeneca’s Farxiga Fails to Yield Statistical Significance for Covid-19 Treatment
April 12, 2021 08:27 PM AEST| By Suhita Poddarand concerns of using SGLT2 inhibitors to treat Covid-19 patients admitted to hospital. Things are not at all smooth for the pharma major AstraZeneca Plc (LON: AZN). After getting mired in various controversies related to its Covid-19 vaccine (....
.jpg)
EMA Supports Astrazeneca Jabs Despite Links with Rare Blood Clots
April 08, 2021 01:55 AM AEST| By AbhijeetSource: LookerStudio, Shutterstock Summary The European Medicines Agency has said that the benefits of using AstraZeneca vaccine outweigh the potential risks it had highlighted before. The MHRA is also scheduled to come up with an up...
10 Cheap Healthcare Stocks to Ponder Over This Easter
April 05, 2021 09:37 AM AEST| By AbhijeetSource: Guschenkova, Shutterstock Summary On a YTD scale, healthcare stocks have multiplied the investors’ wealth by almost 2.5 times. Healthcare sector has a lot of ground to cover, and businesses can access a huge door of growth opport...
.jpg)
Moderna vaccine to be rolled out in April as UK aims to vaccinate all adults by July
March 30, 2021 04:37 AM AEDT| By AbhijeetSource: insta_photos, Shutterstock Summary The UK authorities said that first jabs of Moderna vaccine would be rolled out in April. The Boris Johnson government had said that it was committed to its plans to vaccinate the entire adult populati...
Astrazeneca Vaccine Less Effective Than Earlier Touted, Claims Latest Trial Results
March 25, 2021 09:47 PM AEDT| By AbhijeetSource: PhotobyTawat, Shutterstock Summary The Oxford-AstraZeneca vaccine is 76 per cent effective against the coronavirus infection. The earlier US clinical trial results had put the value a tad higher at 79 per cent. Despite the lower rate,...
.jpg)
AstraZeneca Shares Making ‘Inverse Head And Shoulders’ Pattern Amid Vaccine Chaos
March 20, 2021 01:50 AM AEDT| By AbhijeetSource: PhotobyTawat, Shutterstock Summary Shares of AstraZeneca have experienced a turbulent trading session of late. The stock was trading at GBX 7,133, up 0.07 per cent on 19 March. This year so far, the stock has largely fallen extending...
Vaccine Stocks in Focus as AstraZeneca Awaits EU Verdict on Its Jabs
March 17, 2021 03:00 AM AEDT| By Suhita PoddarSource: Aedka Studio, Shutterstock Summary AstraZeneca has recently faced suspensions from several countries and now is awaiting the EU medical watchdog’s official verdict. The company’s shares are still in the green as the World H...
4 Aspects That Can Decide The Future Of Vaccines
March 16, 2021 02:20 AM AEDT| By AbhijeetSource: insta_photosy, Shutterstock Summary The future of vaccines will depend on several factors such as efficacy of next-generation vaccines, logistical, and distribution issues, fast-tracking approvals and latest innovations and technology....
Vaccine stocks in focus as UK rejects EU’s vaccine export ban claims
March 11, 2021 03:14 AM AEDT| By Team Kalkine MediaSource: PalSand, Shutterstock Summary The British government denied false EU claims over vaccine nationalism concerns. Pandemic seems to have proved the worth of prominent vaccine stocks – AZN, MRNA, PFE and BNTX. A di...
Why Moderna, Pfizer Et Al Are Poised for Strong Gains in FY 2021
March 09, 2021 01:03 AM AEDT| By Suhita PoddarSource: LookerStudio, Shutterstock Summary Several pharmaceutical companies, such as Moderna, Pfizer-BioNTech, Astrazeneca, and others are expected to report huge revenues in FY 2021 as vaccination rollouts gain momentum across the world. Tota...
3 FTSE 250 healthcare stocks with over 25% return in last one year
February 28, 2021 11:58 AM AEDT| By Team Kalkine MediaSource: janews, Shutterstock Summary Three FTSE 250 index stocks have given over 25 per cent return on investment in the last one year. Dechra Pharmaceuticals gave 25.16 per cent, Genus Plc 54.21 per cent, and PureTech Hea...
Will Moderna’s booster shots be effective on South African variant?
February 26, 2021 03:01 AM AEDT| By Team Kalkine MediaSource: joel bubble ben, Shutterstock Summary Moderna said that it has been able to produce booster shots particularly for the South African variant. The shots have been shipped to the National Institutes of Health in...
Avacta (LON: AVCT) Plans Commercial Launch of Lateral Flow Covid-19 Test by Q1
February 25, 2021 05:19 PM AEDT| By Suhita PoddarSource: Horth Rasur, Shutterstock Summary Avacta Group is all set to launch its rapid lateral flow Covid test by Q1 2021. The rapid antigen test has been created to spot infectious people for quick isolation. The company would now work toward...
What are the recent business updates unveiled by LSE listed Clinigen Group?
February 25, 2021 01:42 AM AEDT| By Team Kalkine MediaSource: Shutterstock Summary Clinigen Group PLC had reported an increase of 4% in net organic revenue during H1 FY21 ended 31 December 2020. CLIN had announced an interim dividend of 2.15 pence per share for H1 FY21. Sam Herbert was appointed.....
Will AstraZeneca meet its EU delivery targets for the second quarter?
February 25, 2021 01:21 AM AEDT| By Team Kalkine MediaAstraZeneca PLC (LON: AZN) has expressed its disability to deliver the agreed doses of the Covid-19 vaccine to the European Union, but promised to increase the productivity to meet the demand of 180 million doses. An EU official&n.....
How effective is the Pfizer-BioNtech vaccine against the South African coronavirus strain?
February 18, 2021 10:55 PM AEDT| By Team Kalkine MediaSummary A lab study has found that Pfizer-BioNtech vaccine could be less impactful on South African strain. The vaccine had two-thirds less neutralising impact on antibodies against the South African strain. Though the companies.....
How Kanabo will gain from its smashing debut at London Stock Exchange
February 17, 2021 11:11 PM AEDT| By Hina ChowdharySummary Kanabo came up with an IPO on 16 February which was worth 4.75 pence per share. The shares quadrupled in value at the closing of the first day of trading. Medical marijuana firm Kanabo, also called Nes.....
What Led to A Surge in Astrazeneca’s Product Sales In 2020?
February 12, 2021 01:41 AM AEDT| By Team Kalkine MediaSummary The pharma company announced that its Q4 2020 sales had jumped by 12 per cent to just over $7 billion. The company said it could take about six to nine months to make new vaccines protecting against new strains of the Covid-19 virus. T.....
Dechra Pharma wins licence to sell Tri-Solfen in Australia, NZ
February 10, 2021 01:20 AM AEDT| By Hina ChowdharySummary Dechra Pharmaceuticals announced it had secured the right to sell animal pain management product Tri-Solfen in Australia and New Zealand markets. The pharma company can now market the cattle drug worldwide The Londo.....
AI on the Rise: A Look at Top AI Companies and Their Stocks